Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...

New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data DBS therapy applies mild electrical ...

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing "This is the only directional lead with built-in sensing capabilities," said Jens Volkmann, ...

This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Medtronic plc MDT recently received the FDA’s approval for the Percept RC Deep Brain Stimulation (“DBS”) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept ...

GALWAY, Ireland - Medtronic plc (NYSE:MDT), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $115.42 billion, has announced the FDA approval of its ...

Medtronic plc MDT received the CE Mark for its SenSight directional lead for the treatment of system symptoms associated with movement disorders and epilepsy. SenSight is currently the only available ...

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, today announced the launch of the Percept PC – Deep Brain Stimulation (DBS) system for patients with Parkinson’s disease, ...